Zusammenfassung
Die vorangehende Darstellung der C-Reaktionssequenz bei der Immunhämolyse ging von dem historisch gewachsenen Konzept aus. Bis vor wenigen Jahren war man überzeugt, daß allein die Aktivierung von C1 durch Ag-Ak-Komplexe die C-Reaktion in Gang setzen kann, und daß nur über eine C1-Aktivierung auch die anderen Komponenten aktiviert werden können. Wir wissen heute, daß dieser Zugang zur C-Reaktion und ihren biologischen Auswirkungen nur einer von mehreren ist und vielleicht nicht einmal der bedeutendste.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Alper, C. A., F. S. Rosen and P. J. Lachmann, Inactivator of the third component of complement as an inhibitor in the properdin pathway. Proc. Nat. Acad. Sci. USA 69, 2910 (1972).
Ballow, M. and C. G. Cochrane, Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. J. Immunol. 103, 944 (1969).
Bitter-Suermann, D., Aktivierung des Komplementsystems: Ein Monopol des Immunkomplexes? Klin. Wschr. 50, 277 (1972).
Bitter-Suermann, D., M. Dierich, W. König and U. Hadding, By pass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea pig serum and cobra venom. Immunology 23, 267 (1972).
Bitter-Suermann, D., M. Dierich, W. König and U. Hadding, Enzymatic activation of C3 by a complex derived from a purified cobra venom factor and a serum globulin. J. Immunol. 107, 320 (1971).
Bitter-Suermann, D. und U. Hadding, Untersuchungen über die Auslösung der terminalen Reaktionsschritte bei der Immunhämolyse. Verh. Dtsch. Ges. Path. 54, 276 (1970).
Boenisch, T. and C. A. Alper, Isolation and properties of a glycine-rich γ-glycoprotein of human serum. Biochim. Biophys. Acta 214, 135 (1970 a).
Boenisch, T. and C. A. Alper, Isolation and properties of a glycine-rich ß-glycoprotein of human serum. Biochim. Biophys. Acta 221, 529 (1970 b).
Bokisch, V. A., H. J. Müller-Eberhard and C. G. Cochrane, Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. J. Exp. Med. 129, 1109 (1969).
Borsos, T., H. J. Rapp and U. L. Walz, Action of the first component of complement. Activation of C1 to C1a in the hemolytic system. J. Immunol. 92, 108 (1964).
Budzko, D. B., V. A. Bokisch and H. J. Müller-Eberhard, A fragment of the third component of human complement with anaphylatoxin activity. Biochemistry 10, 1166 (1971).
Budzko, D. B. and H. J. Müller-Eberhard, Anaphylatoxin release from the third component of human complement by hydroxylamine. Science 165, 506 (1969).
Cerottini, J. C. and F. Fitch, Complement fixing ability and antibody activity of rabbit F(ab′)2 antibody. Int. Arch. Allergy Appl. Immunol. 34, 188 (1968).
Chapitis, J., P. A. Ward and I. H. Lepow, Generation of chemotactic activity from human serum and purified components of complement by Serratia proteinase. J. Immunol. 107, 317 (1971).
Coca, A. F., A study of the anticomplementary action of yeast, of certain bacteria and of cobra venom. Z. Immunitätsforsch. 21, 604 (1914).
Cochrane, C. G. and H. J. MüllerEberhard, The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J. Exp. Med. 127, 371 (1968).
Colten, H. R., T. Borsos and H. J. Rapp, Ultracentrifugation of the first component of complement: effects of ionic strength. J. Immunol. 100, 808 (1968).
Dias da Silva, W. and I. H. Lepow, Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement. J. Exp. Med. 125, 921 (1967).
Dias da Silva, W., J. V. Eisele and I. H. Lepow, Complement as a mediator of inflammation. III. Purification of the activity with anaphylatoxin properties by interaction of the first four components of complement and its identification as a cleavage product of C 3. J. Exp. Med. 126, 1027 (1967).
Dierich, M. P., D. Bitter-Suermann, W. König and U. Hadding, Formation and function of a complement-activating enzyme generated from factors of guinea pig serum and cobra venom. Eur. J. Immunol. 1, 309 (1971 a).
Dierich, M. P., D. Bitter-Suermann, W. König and U. Hadding, An efficient model for antibody-independent activation of the complement system. Excerpta med. (Int. Congress series) 235, 11 (1971 b).
Dierich, M., D. Bitter-Suermann, W. König, U. Hadding, C. Galanos and E. T. Rietschel, Analysis of bypass activation of C3 by endotoxic LPS and loss of this potency. Immunology 24, 721 (1973).
Flexner, S. and H. Noguchi, Snake venom in relation to hemolysis, bacteriolysis and toxicity. J. Exp. Med. 6,277 (1903).
Galanos,C., E. T. Rietschel, O. Lüderitz and O. Westphal, Interaction of lipopolysaccharides and lipid A with complement. Eur. J. Biochem. 19, 143 (1971).
Gewurz, H., S. Shin and S. E. Mergenhagen, Interaction of the complement system with endotoxic lipopolysaccharide : consumption of each of the six terminal complement components. J. Exp. Med. 128, 1049 (1968).
Gigli, T., J. W. Mason, R. W. Colman and K. F. Austen, Interaction of kallikrein with the Cl esterase inhibitor (Cla INH). J. Immunol. 101, 814 (1968).
Götze, O. and H. J. Müller-Eberhard, The C3-activator system: An alternate pathway of complement activation. J. Exp. Med. 134, 90s (1971).
Götze, O. and H. J. Müller-Eberhard, Lysis of erythrocytes by complement in the absence of antibody. J. Exp. Med. 132, 898 (1970).
Goodkofsky, I. and I. H. Lepow, Functional relationship of factor B in the properdin system to C3 proactivator of human serum. J. Immunol. 107, 1200 (1971).
Hadding, U., D. Bitter-Suermann and F. Melchert, A tool for the detection of C6 deficiencies. Prot. Biol. Fluids 17, 319 (1969).
Haupt, H. und K. Heide, Isolierung und Eigenschaften eines ß2-Glykoproteins aus Humanserum. Clin. Chim. Acta 12, 419 (1965).
Hill, H. J. and P. A. Ward, The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J. Exp. Med. 133, 885 (1971).
Hill, J. H. and P. A. Ward, C3 leukotactic factors produced by a tissue protease. J. Exp. Med. 130, 505 (1969).
Hunsicker, L. G., S. Ruddy and K. F. Austen, Additional factors required for cobra venom induced activation of C3. Fed. Proc. 31, 788 (Abs.) (1972).
Ishizaka, T., C. M. Sian and K. Ishizaka, Complement fixation by aggregated IgE through alternate pathway. J. Immunol. 108, 848 (1972).
Jasin, N. E., Human heat labile opsonins: Evidence for their mediation via the alternate pathway of complement activation. J. Immunol. 109, 26 (1972).
Jensen, J., Anaphylaxin in its relation to the complement system. Science 155, 1122 (1967).
Johnson, F. R., V. Aquello and R. C. Williams, Opsonic activity in human serum deficient in C2. J. Immunol. 109, 141 (1972).
Kaplan, M. E., A. P. Dalmasso and M. Woodson, Complement-dependent opsonization of incompatible erythrocytes by human secretory IgA. J. Immunol. 108, 275 (1972).
König, W., D. Bitter-Suermann, M. Dierich and U. Hadding, Bypass-activation of the complement system starting with C3. II. C3 activation by γ 1-immune-aggregates in guinea-pig serum. Immunochemistry 10, 431 (1973).
König, W., D. Bitter-Suermann, M. Dierich and U. Hadding, Purification and characterization of properdin from guinea-pig serum. J. exp. Med. submitted for publication (1973).
König, W., D. Bitter-Suermann, M. Dierich and U. Hadding, Direct activation of C3 by γ 1-immune-aggregates from guinea-pig serum. Excerpta med. (Int. congress series) 235, 11 (1971).
Koethe, S. M., K. F. Austen and I. Gigli, Differentiation of binding from complete activation by use of heterologous components of complement. J. Immunol. 108, 1063 (1972).
Lachmann, P. J. and R. A. Thompson, Reactive lysis: The complement- mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9. J. Exp. Med. 131, 643 (1970).
Lepow, I. H., G. B. Naff and J Pensky, Mechanisms of activation of Cl and inhibition of Cl-esterase. In “Ciba Found. Symp., Complement” (G. E. W. Wolstenholme and J. Knight, eds.) Churchill, London, p. 74 (1965).
Lepow, I. H., The properdin system: a review of current concepts. In: Immunochemical approaches to problems in microbiology p. 280 M. Heidelberger and O. J. Plescia, eds. Rutgers University Press, New Brunswick, N. J./ USA 1961.
Lepow, I. H., O. D. Ratnoff, F. S. Rosen and L. Pillemer, Observations on a proesterase associated with partially purified first component of human complement. Proc. Soc. Exp. Biol. Med. 92, 32 (1956).
Lichtenstein, L. M., H. Gewurz, N. F. Adkinson, H. S. Shin and S. E. Mergenhagen, Interaction of the complement system with endotoxix lipopoly saccharide: the generation of anaphylaxtoxin. Immunology 16, 327 (1969).
Loos, M., T. Borsos and H. J. Rapp, The first component of complement in serum. Evidence for a hitherto unrecognized factor in Cl necessary for internal activation. J. Immunol. 110, 205 (1973).
Loos, M., H. U. Wolf and W. Opferkuch, The Cl inactivator from guinea pig serum. III. Characterization and kinetic data of the reaction between the inactivator and EAC1 and EAC14. Immunochemistry 9, 451 (1972).
Lüderitz, O., K. Jann and R. Wheat, Somatic and capsular antigens of gramnegative bacteria. In: Comprehensive biochemistry, 26 A. Elsevier Publ. Co., Amsterdam, London, New York, 1968.
Maillard, J. L. et R. M. Zarco, Decomplementation par un facteur etrait du venin de cobra. Effet sur plusieurs réactions immunes du cobaye et du rat. Ann. Inst. Pasteur 114, 756 (1968).
Malley, A., L. Baecher and D. Burger, The role of complement in allergen-reagin mediated histamine release from monkey lung tissue. Proc. Soc. Exp. Biol. Med. 136, 341 (1971).
May, J. E., I. Green and M. M. Frank, The alternate complement pathway in cell damage: Antibody-mediated cytolysis of erythrocytes and nucleated cells. J. Immunol. 109, 595 (1972).
Mergenhagen, S. E., R. Snydermann, H. Gewurz and H. S. Shin, Significance of complement to the mechanism of action of endotoxin. Curr. Top. Microbiol. Immunol. 50, 37 (1969).
Müller-Eberhard, H. J. and K. E. Fjellström, Isolation of the anticomplementary protein from cobra venom and its mode of action on C3. J. Immunol. 107, 1666 (1972).
Müller-Eberhard, H. J. and O. Götze, C3 proactivator convertase and its mode of action. J. exp. Med. 135, 1003 (1972).
Müller-Eberhard, H. J., Complement. Ann. Rev. Biochem. 38, 389 (1969).
Müller-Eberhard, H. J., Mechanism of inactivation of the third component of human complement (C3) by cobra venom. Fed. Proc. 26, 744 (1967).
Müller-Eberhard, H. J., U. Hadding and M. A. Calcott, Current problems in complement research. In: Immunopathology, Fifth International Symposium (P. Grabar, and P. A. Miescher, eds.). Schwabe u. Co., p. 179 (1967).
Müller-Eberhard, H. J., M. J. Polley and M. A. Calcott, Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement. J. Exp. Med. 125, 359 (1967).
Müller-Eberhard, H. J., U. R. Nilsson, A. P. Dalmasso, M. J. Polley and M. A. Calcott, A molecular concept of immune cytolysis. Arch. Path. 82, 205 (1966).
Naff, G.B. and O. D. Ratnoff, The enzymatic nature of C′lr. Conversion of C′1s to C′l esterase and digestion of amino acid esters by C′lr. J. Exp. Med. 128, 571 (1968).
Nathan, E., Beiträge zur Kenntnis der Inaktivierbarkeit des Meerschweinchenkomplements und ihrer Abhängigkeit von der Serumbeschaffenheit. Z. Immun. Forsch. 26, 503 (1917).
Nelson, R. A., jr.,A new concept of immunosuppression in hypersensitivity reactions and in transplantation immunity. Surv. Ophthal. 11, 498 (1966).
Nelson, R. A., jr., The properdin system: method of measurement and inactivation of human complement components. In: Immunochemical approaches to problems in microbiology p. 295. M. Heidelberger and O. J. Plescia, eds. (New Brunswick, N. J. / USA 1961).
Nelson, R. A., An alternative mechanism for the properdin system. J. Exp. Med. 108, 515 (1958).
Noc, F., Propriétés bactériolytiques et anticytasiques du venin de cobra. Ann. Inst. Pasteur 19, 209 (1905).
Northway, J. D., A. J. McAdams, J. Forristal and C. D. West A “silent” phase of hypocomplementemic persistent nephritis detectable by reduced serum ßlc-globulin levels. J. Pediat. 74, 28 (1969).
Oliveira, B., A. G. Osler, R. P. Siraganian and A. L. Sandberg, The biologic activities of guinea-pig antibodies. I. Separation of γl- and γ2-immunoglobulins and their participation in allergic reactions of the immediate type. J. Immunol. 104, 320 (1970).
Pensky, C. F. Hinz, E. W. Todd, R. J. Wedgewood, J. T. Boyer and I. H. Lepow, Properties of highly purified human properdin. J. Immunol. 100, 142 (1968).
Pinckering, R. J., M. R. Wolfson, R. A. Good and H. Gewurz, Passive hemolysis by serum and cobra venom factor: A new mechanism inducing membrane damage by complement. Proc. Nat. Acad. Sc. 62, 521 (1969).
Pickering, R. J., H. Gewurz and R. A. Good, Complement inactivation by serum from patients with acute and hypocomplementemic chronic glomerulonephritis. J. Lab. Clin. Med. 72, 298 (1968).
Pillemer, L., M. D. Schoenberg, L. Blum and L. Wurz, Properdin system and immunity. II. Interaction of the properdin system with polysaccharides. Science 122, 545 (1955).
Pillemer, L., L. Blum, J. H. Lepow, O. A. Ross, E. W. Todd and A. C. Wardlaw, The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science 120, 279 (1954).
Ratnoff, O. D. and G. B. Naff, The conversion of Cls to Cl esterase by plasmin and trypsin. J. Exp. Med. 125, 337 (1967).
Reid, K. B. M., Complement fixation by the F(ab′)2-fragment of pepsin-treated rabbit antibody. Immunology 20, 649 (1971).
Ritz, H., Über die Wirkung des Cobragiftes auf die Komplemente. J. Immunitätsforsch. 13, 62 (1912).
Root, R. K., L. Ellmann and M. M. Frank, Bactericidal and opsonic properties of C4-deficient guinea-pig serum. J. Immunol. 109, 477 (1972).
Ruddy, S., L.G. Hunsicker and K. F. Austen, C3b inactivator of man. III. Further purification and production of antibody for C3b INA. J. Immunol. 108, 657 (1972).
Sandberg, A. L., R. Snyderman, M. M. Frank and A. G. Osier, Production of chemotactic activity by guinea-pig immunoglobulins following activation of the C3 complement shunt pathway. J. Immunol. 108, 1227 (1972).
Sandberg, A. L., O. Götze, H. J. Müller-Eberhard and A. G. Osier, Complement utilization by guinea-pig γ1- and γ2- immunoglobulins through the C3 activator system. J. Immunol. 107, 920 (1971).
Sandberg, A. L., B. Oliveira and A. G. Osier, Two complement interaction sites in guinea- pig immunoglobulins. J. Immunol. 106, 282 (1971).
Sandberg, A. L., A. G. Osler, H. S. Shin and B. Oliveira, The biologic activities of guinea-pig antibodies. II. Modes of complement interaction with γl- and γ2-immunoglobulins. J. Immunol. 104, 329 (1970).
Schmidt, H., Das Properdin. Fortschritte der Immunitätsforschung Band 2. Steinkopff Verlag, Darmstadt (1959).
Shin, H. S., H. Gewurz and R. Snyderman, Reaction of a cobra venom factor with guinea-pig complement and generation of an activity chemotactic for polymorphonuclear leukocytes. Proc. Soc. Exp. Biol. 131, 203 (1969).
Siraganian, R. P., A. L. Sandberg and A. G. Osier, Lysis of rabbit platelets by F(ab′)2 antibody fragments. J. Immunol. 109, 907 (1972).
Snyderman, R., H. S. Shin, J. K. Phillips, H. Gewurz and S. E. Mergenhagen, A neutrophil chemotactic factor derived from C5 upon interaction of guinea-pig serum with endotoxin. J. Immunol. 103, 413 (1969).
Snyderman, R., H. Gewurz and S. E. Mergenhagen, Interaction of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leucocytes. J. Exp. Med. 128, 259 (1968).
Spitzer, R. E., E. H. Vallota, J. Forristal, E. Sudora, A. Stitzel, N. C. Davis and C. D. West, Serum C3 lytic system in patients with glomerulonephritis. Science 164, 436 (1969).
Stanworth, D. R., Immunoglobulin E (Reagin) and Allergy. Nature 233, 310 (1971).
Taylor, F. B. and P. A. Ward, Generation of chemotactic activity in rabbit serum by plasminogen-streptokinase mixtures. J. Exp. Med. 126, 149 (1967).
Thompson, R. A., C3 inactivating factor in the serum of a patient with chronic hypocomplementaemic proliferative glomerulo-nephritis. Immunology 22, 147 (1972).
Thomson, R. A. and P. J. Lachmann, Reactive lysis: The complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7. J. Exp. Med. 131, 629 (1970).
Thompson, R. A. and D. S. Rowe, Reactive haemolysis a distinctive form of red cell lysis. Immunology 14, 745 (1968).
Vallota, E. H., J. Forristal, R. E. Spitzer, N. C. Davis and C. D. West, Continuing C3 breakdown after bilateral nephrectomy in patients with membranoproliferative glomerulonephritis. J. Clin. Invest. 50, 552 (1971).
Vallota, E. H., J. Forristal, R. E. Spitzer, N. C. Davis and C. D. West, Characteristics of a non-complement-dependent C3-reactive complex formed from factors in nephritic and normal serum. J. Exp. Med. 131, 1306 (1970).
Vogt, W., The anaphylatoxin-forming system. Ergebn. Physiol. 59, 160 (1967).
Vogt, W. und G. Schmidt, Abtrennung des anaphylatoxinbildenden Prinzips aus Cobragift von anderen Giftkomponenten. Experientia 20, 207 (1964).
Ward, P. A. and N. J. Zvaifler, Complement-derived leukotactic factors in inflammatory synovial fluids of humans. J. Clin. Invest. 50, 606 (1971 a).
Ward, P. A. and N. J. Zvaifler, Complement-derived leukotactic factors in human synovial fluids. J. Immunol. 107, 316 (1971 b).
Ward, P. A., M. C. Conroy and I. H. Lepow, Complement derived cleavage products with leukotactic activity generated by streptococcal proteinase. Fed. Proc. 30, 355 (1971).
Ward, P. A. and J. H. Hill, C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J. Immunol. 104, 535 (1970).
Ward, P. A., A plasmin-split fragment of C′3 as a new chemotactic factor. J. Exp. Med. 126, 189 (1967).
Wardlaw, A. C., Endotoxin and complement substrate. In: Bacterial endotoxins p. 81. M.Landy and W. Braun, eds. (New Brunswick, N.J., USA 1964).
Weil, E., Ober die Wirkungsweise des Komplementes bei der Hämolyse. Biochem. 2. 48, 347 (1913).
West, C. D., Serum complement and chronic glomerulonephritis. Hosp. Pract. 5, 75 (1970).
West, C. D., S. Winter, J. Forristal, J. M. McConville and N. C. Davis, Evidence for in vivo breakdown of ßlc-globulin in hypocomplementemic glomerulonephritis. J. Clin. Invest. 46, 539 (1967).
Westberg, N. G., G. B. Naff, J. T. Boyer and A. F. Michael, Glomerular deposition of properdin in acute and chronic glomerulonephritis with hypo- complementemia. J. Clin. Invest. 50, 642 (1971).
Winkelstein, J. A., H. S. Shin and W. B. Wood, Heat labile opsonins to pneumococcus. III. The participation of the immunoglobulin and of the alternate pathway of C3 activation. J. Immunol. 108, 1681 (1972).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Dr. Dietrich Steinkopff Verlag, Darmstadt
About this chapter
Cite this chapter
Rother, K. (1974). Direkte Aktivierung von C3. In: Rother, K. (eds) Komplement. Steinkopff. https://doi.org/10.1007/978-3-642-72310-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-72310-0_4
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-0389-2
Online ISBN: 978-3-642-72310-0
eBook Packages: Springer Book Archive